The Role of MicroRNAs in Acute Respiratory Distress Syndrome and Sepsis, From Targets to Therapies: A Narrative Review.
Lisa K Lee, Lejla Medzikovic, Mansoureh Eghbali...
https://pubmed.ncbi.nlm.nih.gov/33079870/Actively Recruiting
Led by Melike Cengiz · Updated on 2025-12-18
130
Participants Needed
1
Research Sites
17 weeks
Total Duration
This research investigates the relationship between the severity of inflammation and lung function impairment in patients who have experienced trauma. It focuses on how markers of inflammation, such as C-reactive protein, procalcitonin, IL-6, and others, relate to lung injury risk and gas exchange problems. The study also explores the role of circulating microRNA-126 miR-126 in maintaining lung barrier integrity and its potential in reflecting inflammatory burden after trauma. The study observes trauma patients admitted to intensive care units, including those who develop acute respiratory distress syndrome ARDS and those who do not, alongside a control group of healthy volunteers. Researchers collect blood samples, perform ultrasounds to assess vascular function, and measure clinical parameters like blood pressure and heart rate over the first three days of ICU admission. These assessments aim to correlate laboratory inflammation markers, imaging findings, and pulmonary gas-exchange measurements. Participants will be monitored closely for at least three days in intensive care, during which various blood tests, arterial blood gases, and ultrasound imaging are performed. The study measures the primary outcome as the correlation between serum miR-126 levels and lung injury severity in the initial ICU period. Secondary outcomes include levels of IL-6, syndecan, and flow-mediated dilation assessed by ultrasound. The findings may help identify biomarkers useful for predicting lung complications and guiding care after severe trauma.
CONDITIONS
Inflammation Severity and miRNA-126 in Trauma
M
Melike Cengiz, Prof Dr
C
Canberk Kurban
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Melike Cengiz
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At least 3 days after trauma
Participants who have experienced trauma are monitored in the intensive care unit to assess inflammation severity, pulmonary gas exchange, and circulating miR-126 levels.
Daily assessments during ICU stay for up to 3 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Lisa K Lee, Lejla Medzikovic, Mansoureh Eghbali...
https://pubmed.ncbi.nlm.nih.gov/33079870/Pär I Johansson, Hanne H Henriksen, Jakob Stensballe...
https://pubmed.ncbi.nlm.nih.gov/27144442/Melike Cengiz
Lead Sponsor